Detalles de la búsqueda
1.
Efficacy of CAR T-Cell Therapy is Not Impaired by Previous Bispecific Antibody Treatment in Large B-Cell Lymphoma.
Blood
; 2024 04 24.
Artículo
en Inglés
| MEDLINE | ID: mdl-38657242
2.
Prognostic impact of number of induction courses to attain complete remission in patients with acute myeloid leukemia transplanted with either a matched sibling or human leucocyte antigen 10/10 or 9/10 unrelated donor: An Acute Leukemia Working Party European Society for Blood and Marrow Transplantation study.
Cancer
; 2024 Apr 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-38581695
3.
On Behalf of the SFGM-TC: Prophylactic Donor Lymphocyte Infusion in Patients Treated with Allogeneic Stem-Cell Transplantation for High-Risk Myelodysplastic Syndrome and Acute Myeloid Leukemia.
Acta Haematol
; 146(3): 230-239, 2023.
Artículo
en Inglés
| MEDLINE | ID: mdl-36603565
4.
Response to Novel Drugs before and after Allogeneic Stem Cell Transplantation in Patients with Relapsed Multiple Myeloma.
Biol Blood Marrow Transplant
; 25(9): 1703-1712, 2019 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-31054983
5.
Antibody response after 2 and 3 doses of SARS-CoV-2 mRNA vaccine in allogeneic hematopoietic cell transplant recipients.
Blood
; 139(1): 134-137, 2022 01 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-34818411
6.
Persistent cytotoxic T lymphocyte expansions after allogeneic haematopoietic stem cell transplantation: kinetics, clinical impact and absence of STAT3 mutations.
Br J Haematol
; 172(6): 937-46, 2016 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-26728704
7.
Persistence of Yellow Fever Immunization-Induced Antibodies in Allogeneic Hematopoietic Stem Cell Transplant Recipients.
J Infect Dis
; 217(11): 1844-1845, 2018 05 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-29547928
8.
PTCy versus ATG as graft-versus-host disease prophylaxis in mismatched unrelated stem cell transplantation.
Blood Cancer J
; 14(1): 45, 2024 Mar 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38485723
9.
Reactions and adverse events induced by T-cell engagers as anti-cancer immunotherapies, a comprehensive review.
Eur J Cancer
; 205: 114075, 2024 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-38733717
10.
Transfusion needs after CAR T-cell therapy for large B-cell lymphoma: predictive factors and outcome (a DESCAR-T study).
Blood Adv
; 8(6): 1573-1585, 2024 Mar 26.
Artículo
en Inglés
| MEDLINE | ID: mdl-38181767
11.
Post-transplant cyclophosphamide, calcineurin inhibitor, and mycophenolate mofetil compared to anti-thymocyte globulin, calcineurin inhibitor, and methotrexate combinations as graft-versus-host disease prophylaxis post allogeneic stem cell transplantation from sibling and unrelated donors in patients with acute myeloid leukemia: a study on behalf of the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation.
Bone Marrow Transplant
; 2024 Apr 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-38615143
12.
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee.
EClinicalMedicine
; 69: 102476, 2024 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-38361991
13.
Prognostic factors impacting post-transplant outcomes in adult T-cell acute lymphoblastic leukemia: a registry-based study by the EBMT acute leukemia working party.
Bone Marrow Transplant
; 2024 Jun 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-38834689
14.
Allogeneic hematopoietic stem-cell transplantation for patients with Richter transformation: a retrospective study on behalf of the Chronic Malignancies Working Party of the EBMT.
Bone Marrow Transplant
; 2024 Mar 19.
Artículo
en Inglés
| MEDLINE | ID: mdl-38503942
15.
Bone marrow graft versus peripheral blood graft in haploidentical hematopoietic stem cells transplantation: a retrospective analysis in1344 patients of SFGM-TC registry.
J Hematol Oncol
; 17(1): 2, 2024 01 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38185663
16.
Phase II clinical trial for the evaluation of bortezomib within the reduced intensity conditioning regimen (RIC) and post-allogeneic transplantation for high-risk myeloma patients.
Br J Haematol
; 162(4): 474-82, 2013 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-23772672
17.
CAR T-Cells for the Treatment of B-Cell Acute Lymphoblastic Leukemia.
J Clin Med
; 12(21)2023 Oct 31.
Artículo
en Inglés
| MEDLINE | ID: mdl-37959347
18.
[Role of allogeneic hematopoietic cell transplantation after anti-CD19 CAR T-cell treatment: Guidelines from the SFGM-TC]. / Place de l'allogreffe de cellules souches hématopoïétiques après traitement par CAR T-cell anti-CD19 : recommandations de la SFGM-TC.
Bull Cancer
; 110(2S): S108-S115, 2023 Feb.
Artículo
en Francés
| MEDLINE | ID: mdl-35791974
19.
Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.
Immunotherapy
; 15(6): 401-407, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36950962
20.
[Vaccination before and after autologous hematopoietic cell transplantation for autoimmune diseases: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (MATHEC-SFGM-TC)]. / Vaccinations avant et après greffe de cellules hématopoïétiques autologues chez les patients atteints de maladies auto-immunes : propositions du groupe Maladies Auto-immunes et Thérapie Cellulaire de la SFGM-TC.
Bull Cancer
; 110(2S): S97-S107, 2023 Feb.
Artículo
en Francés
| MEDLINE | ID: mdl-36658011